The rems is required by the u.s Food and drug administration (fda) to ensure the benefits of isotretinoin outweigh its risks. The ipledge program rems (risk evaluation and mitigation strategy) the ipledge program rems is a safety program to manage the risk of isotretinoin’s teratogenicity and to minimize fetal exposure. This system is for the use of authorized users only Individuals using this computer system without authority, or in excess of their authority, are subject to having all of their activities on this system monitored and recorded by systems personnel In the, course of monitoring individuals improperly using this system, or in the course of system maintenance, the activities of authorized users.
Ensures that all pharmacy staff using the ipledge rems are aware of the pharmacy’s username, password, and date of personal significance for the ipledge rems website
OPEN
